These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37266107)

  • 1. Cutaneous Adverse Drug Reactions (CADRs) to COVID19 Vaccines: A Case Series.
    Purushottam M; Rangappa V; Betkerur JB; Kombettu AP; Shastry V
    Indian Dermatol Online J; 2023; 14(3):383-387. PubMed ID: 37266107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nevirapine: Most Common Cause of Cutaneous Adverse Drug Reactions in an Outpatient Department of a Tertiary Care Hospital.
    Pawar MP; Pore SM; Pradhan SN; Burute SR; Bhoi UY; Ramanand SJ
    J Clin Diagn Res; 2015 Nov; 9(11):FC17-20. PubMed ID: 26672558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukocytoclastic vasculitis as a cutaneous manifestation of ChAdOx1 nCoV-19 corona virus vaccine (recombinant).
    Sandhu S; Bhatnagar A; Kumar H; Dixit PK; Paliwal G; Suhag DK; Patil C; Mitra D
    Dermatol Ther; 2021 Nov; 34(6):e15141. PubMed ID: 34546608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Cutaneous Adverse Drug Reactions (ADR) Reported at an ADR Monitoring Center of a Tertiary Care Teaching Institute in Central India.
    Chindhalore CA; Gupta AV; Dakhale GN; Srivastava A
    Cureus; 2024 Feb; 16(2):e53706. PubMed ID: 38455795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases.
    Català A; Muñoz-Santos C; Galván-Casas C; Roncero Riesco M; Revilla Nebreda D; Solá-Truyols A; Giavedoni P; Llamas-Velasco M; González-Cruz C; Cubiró X; Ruíz-Villaverde R; Gómez-Armayones S; Gil Mateo MP; Pesqué D; Marcantonio O; Fernández-Nieto D; Romaní J; Iglesias Pena N; Carnero Gonzalez L; Tercedor-Sanchez J; Carretero G; Masat-Ticó T; Rodríguez-Jiménez P; Gimenez-Arnau AM; Utrera-Busquets M; Vargas Laguna E; Angulo Menéndez AG; San Juan Lasser E; Iglesias-Sancho M; Alonso Naranjo L; Hiltun I; Cutillas Marco E; Polimon Olabarrieta I; Marinero Escobedo S; García-Navarro X; Calderón Gutiérrez MJ; Baeza-Hernández G; Bou Camps L; Toledo-Pastrana T; Guilabert A
    Br J Dermatol; 2022 Jan; 186(1):142-152. PubMed ID: 34254291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum of Mucocutaneous Reactions to COVID-19 Vaccination: A Report from a Web-Based Study from India.
    Sil A; Jakhar D; Das A; Jagadeesan S; Aradhya SS
    Indian J Dermatol; 2022; 67(2):115-120. PubMed ID: 36092222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous reactions to COVID-19 vaccines: A review.
    Tan SW; Tam YC; Pang SM
    JAAD Int; 2022 Jun; 7():178-186. PubMed ID: 35194586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pityriasis rosea, pityriasis rosea-like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination.
    Drago F; Broccolo F; Ciccarese G
    Clin Dermatol; 2022; 40(5):586-590. PubMed ID: 35093476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological characteristics of cutaneous complications following COVID-19 vaccination: A case series.
    Diab R; Rakhshan A; Salarinejad S; Pourani MR; Ansar P; Abdollahimajd F
    J Cosmet Dermatol; 2024 Mar; 23(3):725-730. PubMed ID: 37899662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Study to Describe the Pattern of Cutaneous Adverse Effects of COVID-19 Vaccines (Covishield and Covaxin).
    Saraswat N; Tripathy DM; Murali M; Boruah J; Mitra D; Chopra H; Bhatnagar A
    Indian Dermatol Online J; 2023; 14(6):814-820. PubMed ID: 38099027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivated vaccine Covaxin/BBV152: A systematic review.
    Ahmed TI; Rishi S; Irshad S; Aggarwal J; Happa K; Mansoor S
    Front Immunol; 2022; 13():863162. PubMed ID: 36016940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical observation and analysis of skin reactions caused by COVID-19 vaccination.
    Li Y; Fan L; Mao Q; Luan X; Wang Z; Zeng N; Cheng Y; Li Y; Xia Q; Lu Z; Lu Q; Min W; Luo D
    Dermatol Ther; 2022 Oct; 35(10):e15746. PubMed ID: 36190010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders.
    Seirafianpour F; Pourriyahi H; Gholizadeh Mesgarha M; Pour Mohammad A; Shaka Z; Goodarzi A
    Dermatol Ther; 2022 Jun; 35(6):e15461. PubMed ID: 35316551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical profile of cutaneous adverse drug reactions: a retrospective study of 1883 hospitalized patients from 2007 to 2016 in Shanghai, China.
    Yang F; Chen Z; Chen SA; Zhu Q; Wang L; Xiong H; Fu H; Luo X
    Eur J Dermatol; 2020 Feb; 30(1):24-31. PubMed ID: 32031529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin manifestations following anti-COVID-19 vaccination: A multicentricstudy from Turkey.
    Oguz Topal I; Tokmak A; Kurmuş GI; Kalkan G; Demirseren DD; Tosun M; Emre S; Özkök Akbulut T; Kaya Özden H; Koska MC; Külcü Çakmak S; Kutlu Ö; Mutlu E; Gür Aksoy G; Topaloğlu Demir F; Karadağ AS
    J Cosmet Dermatol; 2023 Feb; 22(2):354-363. PubMed ID: 36575896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines for preventing herpes zoster in older adults.
    Gagliardi AM; Andriolo BN; Torloni MR; Soares BG; de Oliveira Gomes J; Andriolo RB; Canteiro Cruz E
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31696946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous manifestations following COVID-19 vaccination: A report of 25 cases.
    Shakoei S; Kalantari Y; Nasimi M; Tootoonchi N; Ansari MS; Razavi Z; Etesami I
    Dermatol Ther; 2022 Aug; 35(8):e15651. PubMed ID: 35716105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous Adverse Drug Reactions in a Tertiary Care Teaching Hospital in India: An Intensive Monitoring Study.
    Thakkar S; Patel TK; Vahora R; Bhabhor P; Patel R
    Indian J Dermatol; 2017; 62(6):618-625. PubMed ID: 29263536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes zoster and simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis.
    Gringeri M; Battini V; Cammarata G; Mosini G; Guarnieri G; Leoni C; Pozzi M; Radice S; Clementi E; Carnovale C
    Expert Rev Vaccines; 2022 May; 21(5):675-684. PubMed ID: 35191364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous findings following COVID-19 vaccination: review of world literature and own experience.
    Gambichler T; Boms S; Susok L; Dickel H; Finis C; Abu Rached N; Barras M; Stücker M; Kasakovski D
    J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):172-180. PubMed ID: 34661927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.